CRP and neoplasm: Because elevated circulating levels of CRP have been frequently found in lung cancer patients [10–12], we hypothesized that CRP may bind to ligands expressed by lung cancer cells or tumor-associated cells and that CRP-bound components in the serum of lung cancer patients may be different from those of healthy subjects.